Correlation between fetal age and ultrasonographic measurements during the second half of pregnancy in domestic cats (Felis catus)

Morphological evaluation of the feline placenta correlates with gene expression of vascular growth factors and receptors†

Placental angiogenesis is critical for normal development. Angiogenic factors and their receptors are key regulators of this process. Dysregulated placental vascular development is associated with pregnancy complications. Despite their importance, vascular growth factor expression has not been thoroughly correlated with placental morphologic development across gestation in cats. We postulate that changes in placental vessel morphology can be appreciated as consequences of dynamic expression of angiogenic signaling agents. Here, we characterized changes in placental morphology alongside expression analysis of angiogenic factor splice variants and receptors throughout pregnancy in domestic shorthair cats. We observed increased vascular and lamellar density in the lamellar zone during mid-pregnancy. Immunohistochemical analysis localized the vascular endothelial growth factor A (VEGF-A) receptor KDR to endothelial cells of the maternal and fetal microvasculatures. PlGF and its principal receptor Flt-1 were localized to the trophoblasts and fetal vasculature. VEGF-A was found in trophoblast cells and associated with endothelial cells. We detected expression of two Plgf splice variants and four Vegf-a variants. Quantitative real-time polymerase chain reaction analysis showed upregulation of mRNAs encoding pan Vegf-a and all Vegf-a splice forms at gestational days 30-35. Vegf-A showed a marked relative increase in expression during mid-pregnancy, consistent with the pro-angiogenic changes seen in the lamellar zone at days 30-35. Flt-1 was upregulated during late pregnancy. Plgf variants showed stable expression during the first two-thirds of pregnancy, followed by a marked increase toward term. These findings revealed specific spatiotemporal expression patterns of VEGF-A family members consistent with pivotal roles during normal placental development.

Reproductive Management in Catteries: Optimising health and wellbeing through veterinarian-breeder collaboration

PRACTICAL RELEVANCE

Many veterinarians - even those engaged in small animal reproduction - are uncomfortable with taking care of cat breeders or being in charge of catteries. Likely reasons for this are that feline reproduction is largely under-represented in undergraduate and graduate reproduction teaching, as well as in postgraduate education and science, whereas cat breeders themselves are often well informed and actively share knowledge with other cat breeders via the internet and social media.

CLINICAL CHALLENGES

A variety of problems can exist within a cattery, and collaboration between veterinarian and breeder to solve these is ultimately beneficial for the breeder, for the veterinarian, and for the health and wellbeing of the individual cats and of the cattery as a whole.

AIM

This review presents a comprehensive overview of aspects of cattery management that might negatively impact reproduction, including sanitation, hygiene and infectious disease control. It also discusses monitoring of reproductive performance, breeding recommendations, and the diagnostic and therapeutic approach to some common and specific problems.

EQUIPMENT AND TECHNICAL SKILLS

Reproductive management in the cattery requires no specialised equipment, as such. What it does need is an open mind, in terms of seeing how things are done, an open ear, for listening to the breeder, and the veterinarian's clinical skills in palpation, auscultation and, where required, further examination of the animals. Keeping abreast of the latest information on infectious diseases, disinfection and genetics ensures proper advice is provided.

EVIDENCE BASE

Current knowledge of reproductive management in catteries is summarised in order to apply an evidence-based approach, whenever possible. Notwithstanding, much of the information remains empirical.

Expression of Anti-Müllerian Hormone and Its Type 2 Receptor in the Ovary of Pregnant and Cyclic Domestic Cats

To evaluate the expression of AMH and its receptor AMHRII, ovaries of 33 p cats were investigated by western blot and immunohistochemistry. After ovariohysterectomy, the cats were grouped according to pregnancy stages and ovarian/placental endocrine activity: group I (n = 3, 24−29 days), II (n = 8, 32−40 days), III (n = 4, 41−46 days), IV (n = 6, 53−61 days) and according to cycle stages: V (n = 6, interestrus) and VI (n = 6, estrus). Serum progesterone- and AMH-concentration was measured. Follicle numbers did not differ between groups. The number of corpora lutea was higher in pregnant cats than in the non-pregnant cats. Serum AMH concentration was at maximum between day 30 and 50 of gestation, and was higher than in non-pregnant cats, then decreased towards term (p < 0.05). In the ovaries, AMH immunopositivity was observed in granulosa cells of secondary and antral follicles, and in interstitial cells of corpora lutea; highest percentage of immunopositive areas was detected in group III (p < 0.05). A positive correlation between the number of corpora lutea and the positive AMH signals in ovarian tissue was determined (r2 = 0.832, p < 0.05); however, only during mid-gestation (group II). Expression of AMHRII was in close co-localization with AMH and strong in the interstitial cells surrounding follicles undergoing atresia. AMHRII expression did not differ between pregnant groups but was higher compared to estrus cats (p ˂ 0.05). We conclude that AMH and AMHRII expression in the feline ovary is comparable to other species. The high serum AMH concentration and ovarian AMHRII expression between day 30 and 50 of gestation are probably related to ovarian activity and follicular atresia.

Feline breeding and pregnancy management: What is normal and when to intervene

Practical relevance:

Cats are common pets worldwide. Successful breeding of cats starts with the selection of suitable breeding animals, and care should be taken to avoid inbreeding. Keeping cats in smaller groups reduces stress and facilitates management.

Clinical challenges:

Breeding cats is challenging in many ways. Group housing is a common scenario, and care should be taken not to have groups that are too large, because of the risk of stress and infectious diseases. Feline pregnancy and parturition both vary in length, which is one reason why it may be challenging to diagnose dystocia. In queens with pyometra, a vaginal discharge may not be evident due to their meticulous cleaning habits.

Audience:

This review is aimed at clinicians in small animal practice, especially those in contact with cat breeders.

Patient group:

Reproductive emergencies occur in both intentionally and unintentionally bred cats, and more often in young or middle-aged queens. Pyometra tends to be a disease of older queens.

Evidence base:

Evidence is poor for many conditions in the breeding queen, and information is extrapolated from the dog or based on case reports and case series.

Aglepristone and cloprostenol combination in the termination of late-term pregnancy in queens

OBJECTIVES

Termination rates for the highly recommended aglepristone (AGL) treatment are low in late-term pregnancy in queens. We studied the effects of an AGL and cloprostenol (CLO) combination in the termination of late-term pregnancy.

METHODS

Pregnant queens were assigned to two groups. Queens in the AGL group (n = 10) received AGL 10 mg/kg, twice, 24 h apart. Queens in the AGL-CLO group (n = 9) were additionally injected with a single dose of CLO (5 μg/kg) 24 h after the second dose of AGL. Progesterone, 17beta(β)-oestradiol, cortisol, oxytocin and prostaglandin F2alpha (PGF2α) metabolite were measured in sera obtained at days 0, 1 and 2, and on the day of abortion.

RESULTS

Average gestational age in both groups was similar (AGL 38.61 ± 0.91 days vs AGL-CLO 39.39 ± 1.35 days; P >0.05). Termination rates were 80% and 100% in the AGL and AGL-CLO groups, respectively (P <0.05). Fetal expulsion time was significantly longer (P <0.001) in the AGL group (96.9 ± 6 h) compared with the AGL-CLO group (69.8 ± 3.3 h). Duration of abortion was 19.8 ± 2.6 h and 12.6 ± 1.4 h in the AGL and AGL-CLO groups, respectively (P <0.05). Both treatments were well tolerated. Significantly (P <0.05) lower serum progesterone concentrations were observed in both groups at the day of abortion and concentrations in the AGL-CLO group (4.19 ± 0.80 ng/ml) were lower than in the AGL group (9.89 ± 2.21 ng/ml; P <0.05).

CONCLUSIONS AND RELEVANCE

AGL and CLO combination increases pregnancy termination rate in late-term pregnant queens. In addition, CLO contributes to a decrease in luteal function in AGL-treated late-term pregnant queens.

Monitoring ovarian function and detecting pregnancy in felids: A review

Reliable detection and monitoring of estrus and pregnancy is essential to the effective ex situ conservation of endangered felids. Here, we review the current methods used to detect estrus and pregnancy in felids and describe the advantages and limitations of each. A total of 194 felid-focused publications were reviewed. The methods used included behavioral assessments (61 publications across 24 species), hormone monitoring (124 studies across 28 species), fecal protein monitoring (two studies in cheetah), ultrasonography (31 publications across seven species), vaginal cytology (22 publications across nine species), and laparoscopy (70 publications across 19 species). Behavior-based assessments of reproductive state are often inconsistent and unreliable in felids; thus hormone measurement is the most frequently used method for monitoring estrous cycles (66% of studies). In non-domestic felids, non-invasive fecal- or urine-based hormone metabolite analyses are preferred to blood assessments (66% of endocrine-based publications). While the measurement of fecal estrogen and progestin metabolites are useful for the retrospective assessment of ovarian activity, their use for real-time detection of estrus is limited. Vaginal cytology, laparoscopy and ultrasonography provide an acute and immediate determination of reproductive state but usually require anesthesia or sedation, which can prevent ovulation and cause abortions; thus, their use for pregnancy diagnosis is limited. Fecal progesterone or prostaglandin F_2α metabolites can be used to detect pregnancy in most felids (the exception being fecal progestins for Lynx spp.), but only during mid-to-late gestation. Urinary relaxin measurement is a promising method for earlier pregnancy diagnosis (30-40% duration of gestation) but is presently limited by poor assay sensitivity due to the lack of a feline-specific relaxin antibody. Elevated levels of fecal immunoglobulin J chain have been investigated as a tool to detect pregnancy in cheetah (>80% accuracy), but research is lacking on other species. We conclude that there is no single 'best method' for monitoring ovarian activity and detecting pregnancy in felids, and current best practice would involve a combination of existing methods. Non-invasive methods for detecting estrus and pregnancy in felids (e.g., accelerometry and infrared thermography) should also be considered to augment existing methods.

Development of specific fetometric formulas of ICC and BP for predicting the parturition date in Maine Coon queens

The objective of study was to derive specific growth curves of ICC and BP for Maine Coon. Twenty-three pregnant queens aged 1-6 years, with body weight of 4.5-7.6 kg, were included in the study. In each queen, serial ultrasonographic examinations of pregnancy were performed through the abdomen with the MyLab Gold Vet scanner with a 6.6-7.5 MHz microconvex probe (Turin, Italy). ICC or BP was measured, depending on the stage of pregnancy. Each examination was regarded as a separate observation. In 18 queens, ICC was measured 33 times, and in 21 queens, BP was measured 60 times. The linear regressions of specific models of ICC and BP in Maine Coon pregnancies and specific formulas for predicting the parturition date in this breed were derived. The ICC formula was: days before parturition (DBP) = -0.79 * mm + 57.9, and the BP formula was: DBP = -1.86 * mm + 49.3. The proposed fetometric formulas of ICC and BP for Maine Coons after application in clinical patients can improve obstetric management in this breed.

Gestational Aging and Determination of Parturition Date in the Bitch and Queen Using Ultrasonography and Radiography

This article provides a complete understanding of how radiography and ultrasound imaging can be used to determine gestational age when inadequate breeding data are available. Formulas for calculation of gestational age using both fetal and extrafetal structures are presented. Ultrasonographic descriptions of organ development and their use in determining gestational age are discussed. This information may be used to monitor the health and development of the fetuses and may be useful when the need to plan an elective or emergency Cesarean section occurs. Ultrasound imaging to assess fetal stress, viability, placental health and to sex fetuses is also described.

Intra- and inter-observer variability in ultrasonographical measurements of the uterus and ovaries in healthy, non-pregnant queens

OBJECTIVES

We aimed to (1) evaluate how frequently the uterus and ovaries of healthy, non-pregnant queens are visible; (2) describe their appearance; (3) take their measurements; and (4) determine intra- and inter-observer variabilities in their measurements. We hypothesised that, using a high-frequency linear probe, the uterus and ovaries could be ultrasonographically visualised during any period of the sexual cycle and with any level of operator expertise.

METHODS

Eight queens were enrolled in the study and the ultrasonographical appearance of their uterus and ovaries assessed with a high-frequency linear probe of 15-19 MHz. The diameter of the uterine horns, body and cervix in transverse and longitudinal sections, and the length of the ovaries were recorded. Three observers of different expertise level participated in the study, and the differences between the separate measurements made per queen were evaluated.

RESULTS

The ovaries and the entire uterus were visualised in every queen. The ovaries were ovoid structures with submillimetric follicles during anoestrus and additional larger follicles depending on the stage of the cycle. An ovarian pattern suggesting cortex and medulla was observed in half the cases. In the uterus, the serosa was a thin hyperechoic outer rim, and layering was observed in half the cases. The cervix was difficult to identify. The intra- and inter-observer variabilities in the uterine horns and the ovaries were minimal (coefficient of variation [CV] 1.4-4.1%) compared with the differences within the queens (CV 10.9-43.4%). The longitudinal and transverse measurements of the horns and the uterine body were the same.

CONCLUSIONS AND RELEVANCE

The ovaries and uterine horns in queens are accessible ultrasonographically at any stage of their cycle, and can be measured with low intra- and inter-observer variabilities.

The expression of leptin receptor in the ovary of the queen: leptin receptor expression in queen ovary

Leptin is a Ob gene product secreted mainly by adipose tissue. Several reports showed leptin production by other tissue including the ovary. The action of leptin is mediated upon binding to its receptor widely expressed in reproductive tissues in different species. In fact, there are growing evidences that leptin plays an important role in the modulation of reproductive functions. Therefore, the aim of this study was to evaluate in the queen, the expression of leptin receptor during the functional ovarian cycle and pregnancy. We found that the ovaries of the queen express leptin receptor in all the examined phases. The highest leptin receptor expression was found in the luteal phase (pseudopregnancy, pregnancy) compared to other phases of the cycle (anestrus, proestrus, estrus). The variations in the expression of leptin receptor suggest a likely implication of leptin in the modulation of ovarian activity, in the examined species.

Feline reproduction: problems and clinical challenges

AUDIENCE

Many veterinarians are closely involved with pedigree cat breeding and have become familiar with the unique characteristics of feline reproduction and breeding management. However, even veterinarians who do not have involvement with the pedigree cat fancy require a basic knowledge of the reproductive problems that are most likely to be encountered in working with non-breeding pet cats as well as stray and feral cats.

CLINICAL CHALLENGES

This article reviews reproductive problems and challenges in both sexes - namely, ovarian remnant syndrome, mammary fibroadenomatous hyperplasia, congenital anomalies of the reproductive tract and pregnancy diagnosis in the queen, and cryptorchidism and low libido in the tom.

EVIDENCE BASE

Feline reproduction has not received the amount of investigation and attention that has been directed at canine reproduction. The result is that less data is available both for description of normal reproduction and for management of common problems. This article reviews most of the available evidence for the conditions discussed. Efforts should focus on making information more readily available to the practitioner and expanding the knowledge base in this important area of feline medicine.

Ultrasonography for pregnancy diagnosis and evaluation in queens

In the present paper, we describe the clinical utility of ultrasonography for diagnosing and evaluating pregnancy in domestic cats. Ultrasonography is a non-invasive technique that permits an accurate diagnosis of pregnancy and allows serial evaluation of the developing embryo/fetus and the extrafetal structures. The first ultrasonographic indication of pregnancy is a gestational chamber seen on day 10 after mating as a small circular anechoic structure. From day 30, it is possible to recognize different fetal organs, and between 38 and 43 days, the gender of the fetus can be determined. Measurements obtained during the second half of gestation can be used to determine fetal age and calculations can then be made that may more accurately predict the time of parturition. Further studies are needed in the queen to determine the applicability of the echo-Doppler technique used routinely in human obstetric medicine. This type of ultrasonography could potentially provide useful information about fetal health and the maturity of the placenta.